yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q38798654-18C1D03A-BA5C-45AB-91DC-713E486E6959
Q38798654-18C1D03A-BA5C-45AB-91DC-713E486E6959
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38798654-18C1D03A-BA5C-45AB-91DC-713E486E6959
The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on mineral metabolism and bone in patients with type 2 diabetes mellitus.
P2860
Q38798654-18C1D03A-BA5C-45AB-91DC-713E486E6959
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38798654-18C1D03A-BA5C-45AB-91DC-713E486E6959
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
10938c69adbe8e5aae1a5c41d4ce1d5870dad099
P2860
Pharmacokinetics and pharmacodynamics of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in subjects with type 2 diabetes mellitus.